MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

Show other versions (1)

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 200%; text-autospace: ideograph-numeric; text-align: justify;"><span style="mso-ansi-language: EN-US; mso-fareast-font-family: Helvetica;" lang="EN-US"><span style...

Full description

Bibliographic Details
Main Author:	Alfredo Marzano
Format:	Article
Language:	English
Published:	PAGEPress Publications 2009-11-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Hepatitis, Immunosuppression, Antiviral Therapy, Lamivudine,
Online Access:	http://www.mjhid.org/article/view/5226

Similar Items

MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
by: Alfredo Marzano
Published: (2009-11-01)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

The efficacy of lamivudine in the treatment of reactivation of chronic hepatitis B virus infection in patients on immunosuppressive therapy
by: Delić Dragan, et al.
Published: (2011-01-01)

HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
by: Xing Cao, et al.
Published: (2021-07-01)

Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: A head-to-head study
by: Shu Yu, et al.
Published: (2014-01-01)

The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation
by: P.H.C. França, et al.
Published: (2007-12-01)

Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01)

Detection of Mutations Resistant to Lamivudine or Adefovir in HBV and Its Management
by: Jia De-xing, et al.
Published: (2013-12-01)

Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
by: Lazarević Ivana, et al.
Published: (2014-01-01)

HBV Reactivation and Lamivudine Treatment in Patients with Lymphoma Undergoing Chemotherapy: Four Cases
by: İlhan AFŞAR, et al.
Published: (2006-12-01)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
by: Erik De Clercq, et al.
Published: (2010-05-01)

Observation on the effect of adefovir dipivoxil in combined with lamivudine in the treatment of hepatitis B cirrhosis
by: Li Cui
Published: (2017-05-01)

THE TACTICS OF ANTIVIRAL THERAPY FOR CHRONIC VIRAL HEPATITIS B IN PREGNANT WOMEN
by: Yuliia Mudra
Published: (2020-10-01)

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

LIVER TRANSPLANTATION AND HBV INFECTION
by: O. I. Andreytseva, et al.
Published: (2009-06-01)

Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma
by: Adriano M. Pellicelli, M.D., et al.
Published: (2014-07-01)

Langzeiteffektivität der Therapie mit Lamivudin bei Patienten mit chronischer Hepatitis-B-Virus-Infektion – Prädiktion des Langzeitansprechens und Spektrum der Resistenzentwicklung
by: Brodzinski, Annika
Published: (2015)

Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCC
by: Charing Ching-Ning Chong, et al.
Published: (2016-03-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia
by: Janudin Baharin, et al.
Published: (2014-03-01)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
by: Zamora FJ, et al.
Published: (2019-10-01)

Treatment or Prophylaxis against Hepatitis B Virus Infection in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: An Update
by: Cristina Stasi, et al.
Published: (2021-06-01)

Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
by: Zhang Dake, et al.
Published: (2012-12-01)

Collapsing glomerulopathy associated with hepatitis B infection: A case report
by: M Mantan, et al.
Published: (2016-01-01)

Efficacy and safety on tenofovire therapy in patients with hepatitis B viral infections resistent to lamivudin
by: Katanić N., et al.
Published: (2015-01-01)

拉米夫定及恩替卡韦预防和治疗非霍奇金淋巴瘤相关性HBV再激活的疗效对比
by: NI Chuanbin
Published: (2014-04-01)

Experience with lamivudine treatment for severe acute hepatitis B
by: Verhaz Antonija
Published: (2014-01-01)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
by: Jian-Lin Chen, et al.
Published: (2016-03-01)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
by: Hyun Young Woo, et al.
Published: (2020-07-01)

Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection
by: Yao Hu, et al.
Published: (2020-06-01)

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
by: Wu Bin, et al.
Published: (2012-11-01)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
by: Vicki Wing-Ki Hui, et al.
Published: (2020-12-01)

Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
by: Emara Mohamed H, et al.
Published: (2011-11-01)

Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy
by: Gabriel Pacífico Seabra Nunes, et al.
Published: (2019-03-01)

The effects of prolonged Lamivudine administration as a sole treatment following the combination therapy of Interferon Alpha and Lamivudine in children for HBeAg (+) chronic hepatitis B
by: Sezin Asik Akman,1 Sabriye Cokceken Okcu,2 Sumer Sutcuoglu.2
Published: (2007-10-01)

Glomerular diseases associated with HBV and HCV infection
by: Boriana Kiperova
Published: (2014-03-01)

Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
by: Aoran Luo, et al.
Published: (2019-07-01)

Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01)

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
by: Andrew Hill, et al.
Published: (2015-04-01)

Untersuchung der HBV-Genotypen bei antiviral behandelten Hepatitis B-Patienten im Zeitraum von 1997 bis 2004 an der Universitätsklinik Würzburg
by: Juling, Martin Johannes
Published: (2010)